austlii:nsw/NSWPICMP/2025/416
General information, not legal advice.
NSWPICMP
2025-06-12
Original judgment source is linked above.
Allaw v Allstaff Australia Sydney Pty Ltd [2025] NSWPICMP 416
WORKERS COMPENSATION - Workplace Injury Management and Workers Compensation Act 1998; review of Medical Assessment Certificate (MAC); appeal against 12% whole person impairment (WPI) assessment regarding lumbar spine; whether a nucleoplasty was a procedure to which Table 4.2 of Chapter 4.37 of the , 5th ed (AMA 5) applied; - the nucleoplasty procedure is not defined within either AMA 5 or the , 4th ed 1 March 2021 (the Guides); however the minimal invasive nature of the procedure was similar to the insertion of a spinal stimulator and was identified by the phrase "or similar device" in Chapter 4.41 of the Guides; no additional WPI was payable; MAC confirmed.
1 March 2021 (the Guides) and the American Medical Association Guides to the Evaluation of Permanent Impairment, 5th ed (AMA 5). "WPI" is reference to whole person impairment.
23 December 2019. This procedure gave Mr Allaw relief for about two years, but the symptoms have subsequently recurred. 4. Mr Allaw's treating specialist has recommended surgery but Mr Allaw has decided against that course of treatment as he is still reasonably mobile and bringing up his children. 5. The Medical Assessor found a WPI of 12%.
a. My opinion and assessment of whole person impairment In my opinion Mr Allaw falls into DRE Category III of his lumbar spine(1) (see 10b) with 10% WPI, with an additional 2% for ADLs, giving a total of 12% WPI.
b. An explanation of my calculations (if applicable)
AMA Guides to the Evaluation of Permanent Impairment, 5th Edition: Page 384, table 15-3. Significant signs of radiculopathy.
c. My brief comments regarding the other medical opinions and findings submitted by the parties and, where applicable, the reasons why my opinion differs I note the reports of treating orthopaedic surgeon, A/Professor P Papantoniou from 4 June 2019 to 11 July 2023, noting the ongoing back pain and bilateral sciatica, which was felt to be 'relatively mild', and suggesting that at some stage Mr Allaw may well require surgery to his lumbar spine.
There are reports of Dr J B Bodel, orthopaedic surgeon of 18 May 2023, noting the
significant disc injury at the lumbosacral level with referred pain to the right lower limb, with significant restriction of back movement and a depressed right ankle jerk, and wasting of the right calf. He also noted restricted straight leg raising on the right side.
Dr Bodel placed Mr Allaw in DRE Category III as I have done, but for different reasons,
suggesting that he had placed him in this category following the nucleoplasty. In my opinion nucleoplasty would not be regarded as surgery to the lumbar spine as it is a form of therapy. It would fall into the same category as a spinal cord stimulator, and not giving any additional impairment.
Dr Bodel has suggested an additional 3% for radiculopathy, but as noted in my opinion Mr Allaw's impairment is best assessed in terms of DRE Category III with radiculopathy, rather than for the nucleoplasty. This explains the difference in our impairment assessments.
There is a report of A/Professor C Waller, orthopaedic surgeon of 31 July 2023, similarly placing Mr Allaw in DRE Category III of his lumbar spine, awarding 10% for the nucleoplasty and 3% for ADLs, whereas in my opinion 2% for ADLs would be more appropriate. Once again in my opinion placing somebody in DRE Category III for a nucleoplasty is inappropriate."
"Significant signs of radiculopathy, such as dermatomal pain and/or in a dermatomal distribution, sensory loss, loss of relevant reflex(es), loss of muscle strength or measured unilateral atrophy above or below the knee compared to measurements on the contralateral side at the same location; impairment may be verified by electrodiagnostic findings
history of a herniated disc at the level and on the side that would be expected from objective clinical findings, associated with radiculopathy, or individuals who had surgery for radiculopathy but are now asymptomatic.
"4.37 Effect of surgery: AMA5 tables 15-3 to 15-5 (pp 384, 389 and 392) do not adequately account for the effect of surgery on the impairment rating for certain disorders of the spine. The assessor should note that:
•• Surgical decompression for spinal stenosis is DRE category III (AMA5 Table 15-3, 15-4 or 15-5)
•• Operations where the radiculopathy has resolved are considered under the DRE category III (AMA5 Table 15-3, 15-4 or 15-5).
•• Operations for spinal fusion (successful or unsuccessful) are considered under DRE category IV (AMA5 Table 15-3, 15-4 or 15-5)
•• DRE category V is not to be used following spinal fusion where there is a persisting radiculopathy. Instead, use Table 4.2 in the Guidelines
•• Radiculopathy persisting after surgery is not accounted for by AMA5 Table 15-3, and incompletely by tables 15-4 and 15-5, which only refer to radiculopathy that has improved following surgery.
Table 4.2 indicates the additional ratings which should be combined with the rating determined using the DRE method where an operation for an intervertebral disc prolapse, spinal canal stenosis or spinal fusion has been performed.
Example 15-4 in AMA5 (p 386) should therefore be ignored.
Table 4.2: Modifiers for DRE categories following surgery
and radiculopathy (refer to 4.27 in the Guidelines)
In summary, to calculate whole person impairment (WPI) for persisting radiculopathy (as per definition) following surgery:
•• Select the appropriate DRE category from Table 15-3, 15-4, or 15-5;
•• Determine a WPI value within the allowed range in Table 15-3, 15-4 or 15-5 according to the impact on the worker's ADL
•• Combine this value with the appropriate additional amount from Table 4.2 to determine the final WPI."
"Spinal cord stimulator or similar device: The insertion of such devices does not warrant any additional WPI."
Allaw
Allstaff Australia Sydney Pty Ltd [2025] NSWPICMP 416